Should a patient with low bone density in the forearm and a T-score below -2.5 be treated with antiresorptive therapy?
Fuente:
Zenodo
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Recurso digital |
| Veröffentlicht: |
Zenodo
2026
|
| Schlagworte: | |
| Online-Zugang: | |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| _version_ | 1866901349257445376 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Patients with a T-score below -2.5 are usually considered for antiresorptive therapy due to their increased risk for fractures, with treatments like bisphosphonates or denosumab being common options. Comprehensive risk assessments are essential to inform individual treatment decisions. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19227037 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | Should a patient with low bone density in the forearm and a T-score below -2.5 be treated with antiresorptive therapy? Tripdatabase low bone density forearm T-score antiresorptive therapy osteoporosis fracture risk bone health treatment endocrinology orthopaedics Patients with a T-score below -2.5 are usually considered for antiresorptive therapy due to their increased risk for fractures, with treatments like bisphosphonates or denosumab being common options. Comprehensive risk assessments are essential to inform individual treatment decisions. |
| title | Should a patient with low bone density in the forearm and a T-score below -2.5 be treated with antiresorptive therapy? |
| topic | low bone density forearm T-score antiresorptive therapy osteoporosis fracture risk bone health treatment endocrinology orthopaedics |
| url | https://doi.org/10.5281/zenodo.19227037 |